Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus.
Publication
, Journal Article
Chen, A; Yoshizaki, A; Miyagaki, T; Streilein, RD; Tedder, TF; Hall, RP
Published in: J Invest Dermatol
February 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Invest Dermatol
DOI
EISSN
1523-1747
Publication Date
February 2021
Volume
141
Issue
2
Start / End Page
443 / 446
Location
United States
Related Subject Headings
- Treatment Outcome
- Rituximab
- Pemphigus
- Mycophenolic Acid
- Lymphocyte Count
- Interleukin-10
- Immunosuppressive Agents
- Humans
- Glucocorticoids
- Drug Therapy, Combination
Citation
APA
Chicago
ICMJE
MLA
NLM
Chen, A., Yoshizaki, A., Miyagaki, T., Streilein, R. D., Tedder, T. F., & Hall, R. P. (2021). Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus. J Invest Dermatol, 141(2), 443–446. https://doi.org/10.1016/j.jid.2020.06.018
Chen, Alan, Ayumi Yoshizaki, Tomomitsu Miyagaki, Robert D. Streilein, Thomas F. Tedder, and Russell P. Hall. “Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus.” J Invest Dermatol 141, no. 2 (February 2021): 443–46. https://doi.org/10.1016/j.jid.2020.06.018.
Chen A, Yoshizaki A, Miyagaki T, Streilein RD, Tedder TF, Hall RP. Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus. J Invest Dermatol. 2021 Feb;141(2):443–6.
Chen, Alan, et al. “Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus.” J Invest Dermatol, vol. 141, no. 2, Feb. 2021, pp. 443–46. Pubmed, doi:10.1016/j.jid.2020.06.018.
Chen A, Yoshizaki A, Miyagaki T, Streilein RD, Tedder TF, Hall RP. Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus. J Invest Dermatol. 2021 Feb;141(2):443–446.
Published In
J Invest Dermatol
DOI
EISSN
1523-1747
Publication Date
February 2021
Volume
141
Issue
2
Start / End Page
443 / 446
Location
United States
Related Subject Headings
- Treatment Outcome
- Rituximab
- Pemphigus
- Mycophenolic Acid
- Lymphocyte Count
- Interleukin-10
- Immunosuppressive Agents
- Humans
- Glucocorticoids
- Drug Therapy, Combination